Medscape Scribe

The artifact is wholly model generated, but the competitive asset is the audience rather than the model. Medscape is a clinical information business whose reach across United States physicians long predates this product, and Scribe is given away inside it. Same reasoning applied to Doximity Scribe: nothing is sold on model quality, so adoption follows distribution and price.

Draft and review, with a named review step rather than an implied one: the product includes a feature called Scribecheck for quick review of generated output before use. Naming and shipping a review affordance is more than most free tools do. Held at B because no acceptance rate, edit burden figure or confidence threshold is published, and because no EHR write back was located, meaning the clinician necessarily handles the note anyway.

No accuracy figure, model card, named models or evaluation methodology located. Capability is described functionally, real time transcription and template based summarisation, with no measurement attached.

No study, controlled evaluation, accuracy benchmark, third party rating or published adoption figure located. Launch materials describe expected benefits rather than measured ones.

One specific, checkable commitment: transcripts are AUTOMATICALLY DELETED AFTER 72 HOURS. A published retention window is rare in this category and it is the kind of statement a buyer can hold a vendor to. Held at B rather than A because it is the only commitment located: it covers transcripts rather than audio, and nothing was found on whether content is used to train models, which is the disclosure that separates the A grades on this axis.

Described as HIPAA compliant with patient data security emphasised. Business associate agreement terms are not published, and because the tool is free and reached inside an account a clinician already holds, use can begin with no agreement conversation at all, which is the same governance gap this index flags for Doximity Scribe.

Not assessed. No named or dated attestation and no trust centre located for this product in this pass.

Not a regulated medical device and none claimed or required for ambient documentation.

Nothing located. No fairness statement, subgroup analysis or accent and dialect performance disclosure. As with Doximity, the absence carries more weight because of reach: a free tool distributed inside a service most United States physicians already use will encounter the full range of patient speech, and any performance variation propagates nationally rather than within one practice.

Not assessed. No electronic health record integration, write back mechanism or named system was located; the product lives in the Medscape application and website, which implies the clinician moves the note manually, but nothing states this either way.

Not assessed. Delivered through the Medscape mobile application and website, but no hosting region, residency detail or sub processor information was located.

Free, stated plainly, with eligibility bounded and published: physicians in the United States, reached through an existing Medscape account with no tier, no quote and no procurement step. As with Doximity Scribe, a published zero is the most transparent commercial position available, and its market effect is to remove note generation as a thing anyone can charge a premium for on its own.

Template coverage is stated and slightly unusual in composition: SOAP, history and physical, and the PROBLEM ORIENTED MEDICAL RECORD, the last being a structure organised by problem rather than by visit, which almost no competitor offers as a standard template and which suits longitudinal care. Against that, availability is restricted to physicians in the United States, no specialty count or tuning is described, and no language coverage was located.